严重营养不良合并重度脱水患儿静脉补液的系统评价与荟萃分析
该研究比较严重急性营养不良(SAM)合并重度脱水患儿采用静脉补液(IVR)与口服补液(OR)的疗效与安全性,纳入3项随机对照试验共484例。汇总分析显示,IVR组院内死亡风险比OR组低(RR 0.71,95%CI 0.46至1.10),且24小时严重低钠血症风险更低(RR 0.66,95%CI 0.44至0.99),液体超负荷事件未见增加。
要点
- IVR vs OR的院内死亡汇总RR为0.71(95%CI 0.46至1.10),证据确定性中等。
- 24小时严重低钠血症(钠<125或<130 mmol/L)汇总RR为0.66(95%CI 0.44至0.99)。
- 液体超负荷事件汇总RR为0.99(95%CI 0.10至9.35),未见明显增加。
核心结论
- 在SAM合并重度脱水患儿中,IVR相比OR的死亡风险估计范围从相对降低54%到相对增加10%,且IVR不良事件更少。
研究设计与样本
- 系统评价与荟萃分析,纳入3项随机对照试验共484例严重营养不良患儿,其中72例为夸希奥科病。
- 研究地点为低至中等收入国家,比较IVR与OR(标准治疗)在因胃肠炎导致重度脱水的住院SAM患儿中的效果。
主要发现
- IVR vs OR的院内死亡汇总RR为0.71(95%CI 0.46至1.10;I2=0.0%),证据确定性中等。
- 液体超负荷事件汇总RR为0.99(95%CI 0.10至9.35)。
- 24小时严重低钠血症(钠<125或<130 mmol/L)汇总RR为0.66(95%CI 0.44至0.99)。
- 仅1项试验报告IVR vs OR的休克发生RR为0.56(95%CI 0.21至1.48)、高钠血症(钠>145 mmol/L)RR为2.05(95%CI 0.50至8.58)、28天死亡RR为0.85(95%CI 0.44至1.65)。
- 院内死亡亚组分析按地区和偏倚风险评级进行,异质性检验p值分别为0.85和0.54。
关键数值与推荐
- 主要结局为院内死亡,次要结局包括液体超负荷事件、需静脉推注的休克发生、24小时严重电解质异常及28天死亡。
- 3项试验中2项存在一定偏倚风险,1项为低偏倚风险。
临床怎么用
- 对于SAM合并重度脱水的住院患儿,IVR可能降低院内死亡风险且未增加液体超负荷,但证据确定性中等,需结合临床评估个体化选择补液方式。
局限性
- 仅纳入3项随机对照试验共484例,样本量有限。
- 2项试验存在一定偏倚风险。
- 休克发生、高钠血症和28天死亡仅由1项试验报告,结果不确定性大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare the efficacy and safety of intravenous rehydration (IVR) versus oral rehydration (OR) strategies in children with severe acute malnutrition (SAM) and severe dehydration. DESIGN: Systematic review and meta-analysis. SETTING: Lower-to-middle-income countries. PATIENTS: Children with SAM are hospitalised with severe dehydration secondary to gastroenteritis. INTERVENTIONS: Randomised trials of IVR and OR (standard of care) MAIN OUTCOME MEASURES: Primary: in-hospital mortality. Secondary: fluid overload events, development of shock requiring intravenous boluses, severe electrolyte abnormalities at 24 hours and day 28 mortality. RESULTS: We identified three RCTs comprising 484 participants with severe malnutrition (72 had kwashiorkor, two had some risk of bias, and one had low risk of bias). The pooled risk ratio (RR) for in-hospital mortality for IVR versus OR is 0.71 (95% CI 0.46 to 1.10; I2=0.0%) with moderate certainty of evidence. No fluid overload events were reported, pooled RR 0.99 (95% CI 0.10 to 9.35). The pooled RR of severe hyponatraemia (sodium <125 or <130 mmol/L) at 24 hours was 0.66 (95% CI 0.44 to 0.99). Only one trial reported RR for shock development, hypernatraemia (sodium >145 mmol/L) or 28-day mortality with IVR versus OR (RRs 0.56, 95% CI 0.21 to 1.48; RR 2.05, 95% CI 0.50 to 8.58 and RR 0.85, 95% CI 0.44 to 1.65, respectively). Subgroup analyses for in-hospital mortality were carried out for region and risk of bias rating, giving p=0.85 and p=0.54 for heterogeneity, respectively. CONCLUSIONS: The estimated effect of using IVR versus OR in children with SAM with severe dehydration ranges from a 54% relative reduction to a 10% relative increase in the risk of death, with IVR resulting in fewer adverse events. PROSPERO REGISTRATION NUMBER: CRD42025637956.
引用
- Dewez JE, Ouattara SM, Sunyoto T, et al. Intravenous rehydration in children with severe malnutrition and severe dehydration: a systematic review and meta-analysis. Arch Dis Child. 2026. PMID: 42161576. doi:10.1136/archdischild-2026-330358
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。